SCHEMBL31745441

SCHEMBL31745441

Fc1ccc(N2CCN(c3ncnc4ccc(Cl)cc34)CC2)c(F)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.59
CYP1A2 P05177 2/20 0.45
CYP2D6 P10635 2/20 0.45
ACHE P22303 3/20 0.45
BACE1 P56817 3/20 0.45
AKT1 P31749 2/20 0.45
CHRM4 P08173 1/20 0.44
PDGFRB P09619 1/20 0.44
AURKA O14965 1/20 0.43
MAPK1 P28482 2/20 0.43
ALDH1A1 P00352 2/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HIF1A Q16665 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
RPS6KB1 P23443 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31745367 0.84 HTT (0.63) HTTCYP1A2CYP2D6ACHEBACE1
SCHEMBL30734212 0.79 HTT (0.49) HTTCYP1A2CYP2D6PDGFRBMAPK1
SCHEMBL2923518 0.75 HTT (0.70) HTTCYP1A2CYP2D6MAPK1ALDH1A1
SCHEMBL31745315 0.73 HTT (0.63) HTTCYP1A2CYP2D6ACHEBACE1
SCHEMBL27339114 0.72 HTT (0.65) HTTCYP1A2CYP2D6ACHEBACE1
SCHEMBL2922462 0.72 HTT (0.70) HTTCYP1A2CYP2D6ACHEBACE1
SCHEMBL30734224 0.72 HTT (0.64) HTTCYP1A2CYP2D6ACHEBACE1
SCHEMBL31745374 0.71 HTT (0.59) HTTCYP1A2CYP2D6ACHEBACE1
SCHEMBL19357723 0.71 USP30 (0.41) HTTALDH1A1LMNAMAPT
SCHEMBL717642 0.70 HTT (0.62) HTTACHEBACE1CHRM4PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF UNIV ARIZONA (US) 2025-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382301-A1 SMALL MOLECULE INHIBITORS OF DYRK/CLK AND USES THEREOF CLK2, CLK3, CLK1 HTT 713/4885CYP1A2 3648/4885CYP2D6 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.